Erlotinib hydrochloride. [Nat Rev Drug Discov. 2005] - PubMed

Save items

loading

Related citations in PubMed

Review Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. [Oncologist. 2009]
Review Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.
Morabito A, Piccirillo MC, Falasconi F, De Feo G, Del Giudice A, Bryce J, Di Maio M, De Maio E, Normanno N, Perrone F. Oncologist. 2009 Apr; 14(4):378-90. Epub 2009 Apr 6.
Review Erlotinib: a new therapeutic approach for non-small cell lung cancer. [Expert Opin Investig Drugs. 2003]
Review Erlotinib: a new therapeutic approach for non-small cell lung cancer.
Bonomi P. Expert Opin Investig Drugs. 2003 Aug; 12(8):1395-401.
Review Phase II data with ZD6474, a small-molecule kinase inhibitor of epidermal growth factor receptor and vascular endothelial growth factor receptor, in previously treated advanced non-small-cell lung cancer. [Clin Lung Cancer. 2005]
Review Phase II data with ZD6474, a small-molecule kinase inhibitor of epidermal growth factor receptor and vascular endothelial growth factor receptor, in previously treated advanced non-small-cell lung cancer.
Lee D. Clin Lung Cancer. 2005 Sep; 7(2):89-91.
Review Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib. [Oncology (Williston Park). 2003]
Review Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.
Sandler A. Oncology (Williston Park). 2003 Nov; 17(11 Suppl 12):17-22.
Gefitinib plus docetaxel in non-small-cell lung cancer. [Lancet. 2009]
Gefitinib plus docetaxel in non-small-cell lung cancer.
Costa DB, Kobayashi S. Lancet. 2009 Feb 14; 373(9663):541; author reply 542.

See reviews... See all...

Cited by 3 PubMed Central articles

Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity. [J Proteome Res. 2011]
Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.
Zhang G, Fang B, Liu RZ, Lin H, Kinose F, Bai Y, Oguz U, Remily-Wood ER, Li J, Altiok S, et al. J Proteome Res. 2011 Jan 7; 10(1):305-19. Epub 2010 Dec 3.
Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and Abl. [PLoS One. 2009]
Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and Abl.
Yang LJ, Zou J, Xie HZ, Li LL, Wei YQ, Yang SY. PLoS One. 2009 Dec 24; 4(12):e8470. Epub 2009 Dec 24.
EGFR associated expression profiles vary with breast tumor subtype. [BMC Genomics. 2007]
EGFR associated expression profiles vary with breast tumor subtype.
Hoadley KA, Weigman VJ, Fan C, Sawyer LR, He X, Troester MA, Sartor CI, Rieger-House T, Bernard PS, Carey LA, et al. BMC Genomics. 2007 Jul 31; 8:258. Epub 2007 Jul 31.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Erlotinib hydrochloride.
Erlotinib hydrochloride.
Nat Rev Drug Discov. 2005 Jan ;4(1):13-4.

PubMed
The lrp gene product regulates expression of lysU in Escherichia coli K-12.
The lrp gene product regulates expression of lysU in Escherichia coli K-12.
J Bacteriol. 1992 May ;174(9):2779-84.

PubMed
SOCS2 negatively regulates growth hormone action in vitro and in vivo.
SOCS2 negatively regulates growth hormone action in vitro and in vivo.
J Clin Invest. 2005 Feb ;115(2):397-406.

PubMed
Differential age effects for components of the adult auditory middle latency res...
Differential age effects for components of the adult auditory middle latency response.
Hear Res. 1992 Mar ;58(2):123-31.

PubMed
Spindle abnormalities in normally developing and arrested human preimplantation ...
Spindle abnormalities in normally developing and arrested human preimplantation embryos in vitro identified by confocal laser scanning microscopy.
Hum Reprod. 2005 Mar ;20(3):672-82. Epub 2005 Feb 2 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Erlotinib hydrochloride.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Education

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information